|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM331035618 |
| 003 |
DE-627 |
| 005 |
20250302125748.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2021 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202007949
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1103.xml
|
| 035 |
|
|
|a (DE-627)NLM331035618
|
| 035 |
|
|
|a (NLM)34561899
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Yi, Sang Ah
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Bioengineering Approaches for the Advanced Organoid Research
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 23.02.2022
|
| 500 |
|
|
|a Date Revised 08.11.2023
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2021 Wiley-VCH GmbH.
|
| 520 |
|
|
|a Recent advances in 3D cell culture technology have enabled scientists to generate stem cell derived organoids that recapitulate the structural and functional characteristics of native organs. Current organoid technologies have been striding toward identifying the essential factors for controlling the processes involved in organoid development, including physical cues and biochemical signaling. There is a growing demand for engineering dynamic niches characterized by conditions that resemble in vivo organogenesis to generate reproducible and reliable organoids for various applications. Innovative biomaterial-based and advanced engineering-based approaches have been incorporated into conventional organoid culture methods to facilitate the development of organoid research. The recent advances in organoid engineering, including extracellular matrices and genetic modulation, are comprehensively summarized to pinpoint the parameters critical for organ-specific patterning. Moreover, perspective trends in developing tunable organoids in response to exogenous and endogenous cues are discussed for next-generation developmental studies, disease modeling, and therapeutics
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a bioengineered organoids
|
| 650 |
|
4 |
|a biomaterials
|
| 650 |
|
4 |
|a disease modeling
|
| 650 |
|
4 |
|a extracellular matrix
|
| 650 |
|
4 |
|a genetic engineering
|
| 650 |
|
7 |
|a Biocompatible Materials
|2 NLM
|
| 650 |
|
7 |
|a Hydrogels
|2 NLM
|
| 700 |
1 |
|
|a Zhang, Yixiao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Rathnam, Christopher
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Pongkulapa, Thanapat
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lee, Ki-Bum
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 33(2021), 45 vom: 05. Nov., Seite e2007949
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnas
|
| 773 |
1 |
8 |
|g volume:33
|g year:2021
|g number:45
|g day:05
|g month:11
|g pages:e2007949
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202007949
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 33
|j 2021
|e 45
|b 05
|c 11
|h e2007949
|